Starrag Group Holding AG (STGN)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 23 Oct 2026
Key indicators
| Last close | CHF 35.80 |
|---|---|
| 52-week range | 28.00 – 37.50 |
| Return, 1 month / 3 months | +6.9% / +5.9% |
| Return, 1 year / 3 years | +15.7% / −23.4% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 35.2% |
| Worst drawdown (1 year) | -12.0% |
| Average daily value traded | 0.05M CHF |
| Dividend yield | 1.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Starrag Group Holding AG is a Swiss maker of precision machine tools, based in Switzerland. The company builds milling, turning, boring and grinding machines and machining centres, along with related services and automation. Its customers are manufacturers in aerospace, energy, industrial machinery and transport, who use the equipment to machine metal components to tight tolerances. Starrag supplies machines and support to factories in several countries.
The shares are listed on the SIX Swiss Exchange in Switzerland under the code STGN, and the price on this page is in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Starrag Group Holding AG (STGN) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 35.80 on 23 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 108 of 226 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 15.7% and over the last three months it rose 5.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.9% | ||
| From 52-week high | -4.5% | ||
| Momentum | 58 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.9% | ||
| 6-month return | 5.9% | ||
| 12-month return, skipping the last month | 8.3% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.0% | ||
| Liquidity | 19 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.05M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 38 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | +6.9% |
| 3 months | +5.9% |
| 6 months | +5.9% |
| 1 year | +15.7% |
| 3 years | −23.4% |
| 5 years | −17.2% |
Signals
| 50-day / 200-day average | 34.70 / 33.18 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.86 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Apr 2026 | CHF 0.5000 |
| 24 Apr 2025 | CHF 0.5000 |
| 24 Apr 2024 | CHF 1.2500 |
| 25 Apr 2023 | CHF 1.0000 |
| 26 Apr 2022 | CHF 0.5000 |
| 30 Apr 2019 | CHF 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.